Mary Szela

Mary Szela appears in our data through filings on Novelion Therapeutics Inc. shares, published by SEDI. We count 3 filings; the first trade dates from 29 November 2016 and the latest from 9 May 2017.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 11 May 2017, reports a transaction of €14k in Novelion Therapeutics Inc. Filings reach the SEDI feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.